Multicenter,Randomized, Double-Blind Placebo- Controlled Study of Subcutaneous Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense in Patients With Hypersensitivity to Grass Pollen.

Trial Profile

Multicenter,Randomized, Double-Blind Placebo- Controlled Study of Subcutaneous Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense in Patients With Hypersensitivity to Grass Pollen.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jan 2014

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jan 2014 According to ClinicalTrials.gov record study status changed from active, no longer recruiting to completed.
    • 16 Oct 2012 Additional trial identifier (6043-PG-PSC-153) added.
    • 27 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top